Parnpen Viriyavejakul
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Parnpen Viriyavejakul has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
- Chuchard Punsawad
Center of Excellence in Tropical Pathobiology, Walailak University, Nakhon Si Thammarat 80160, Thailand
12 shared publications Supattra Glaharn
Department of Tropical Pathology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
12 shared publicationsSrivicha Krudsood
Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
10 shared publicationsChuchard Punsawad
Department of Medical Science, School of Medicine, Walailak University, Nakhon Si Thammarat, Thailand
9 shared publicationsUrai Chaisri
Department of Tropical Pathology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
6 shared publicationsAekkarin Klinkhamhom
Department of Tropical Pathology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
5 shared publications
Latest Publications
- Open Access
- 24 June 2026
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 11 (7) , 172
Ultrasound-Based Staging and Its Impact on Clinical Management of Hepatic Hydatid Cysts in an Endemic Setting: A Cross-Sectional Study in Eastern Afghanistan
Background: Hydatid disease, caused by Echinococcus granulosus, remains a significant public health concern in endemic regions. This study aimed to evaluate the role of ultrasound in the diagnosis, staging, and clinical management of liver hydatid cysts in the eastern city of Jalalabad, Afghanistan. Method: A cross-sectional study was conducted between February and November 2024 among 159 patients diagnosed with liver hydatid cysts. Demographic, clinical, laboratory, and imaging data were collected. Cysts were classified according to the WHO Informal Working Group on Echinococcosis (WHO-IWGE) and Gharbi systems. Ultrasound findings were compared with computed tomography (CT), and their association with treatment decisions was assessed. Result: A total of 159 patients with liver hydatid cysts were included in the study. Among them, 91 (57.2%) were female, 80 (50.3%) were aged 20–39 years, and 128 (80.5%) resided in rural areas. Most patients presented with a single cyst (144/159, 90.6%), while multiple cysts were observed in 15 (9.4%). The majority of cysts measured 5–9.9 cm in diameter (43.4%), followed by 1–4.9 cm (42.1%) and ≥10 cm (14.5%). According to the WHO-IWGE classification, CE1 (25.8%) and CE4 (24.5%) were the most common stages, followed by CE2 (17.6%), CE3a (13.8%), CE3b (11.3%), and CE5 (7.0%). Common exposure-related factors included dog ownership, poor hygiene practices, and consumption of raw vegetables. Ultrasound accurately identified cyst stages and demonstrated a significant association between WHO-IWGE staging and treatment modality (χ2 = 63.56, p < 0.001). Almost perfect agreement was observed between ultrasound and CT for cyst classification (Cohen’s κ > 0.90), although CT provided additional anatomical information in selected complex cases. Conclusions: Ultrasound is an accessible, accurate, and reliable imaging modality for the diagnosis, staging, and management of liver hydatid cysts. In resource-limited settings, it serves as the primary imaging modality for guiding clinical decision-making, with CT reserved for complex or uncertain cases.
- 24 June 2026
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 11 (7) , 172
Open AccessUltrasound-Based Staging and Its Impact on Clinical Management of Hepatic Hydatid Cysts in an Endemic Setting: A Cross-Sectional Study in Eastern Afghanistan
Background: Hydatid disease, caused by Echinococcus granulosus, remains a significant public health concern in endemic regions. This study aimed to evaluate the role of ultrasound in the diagnosis, staging, and clinical management of liver hydatid cysts in the eastern city of Jalalabad, Afghanistan. Method: A cross-sectional study was conducted between February and November 2024 among 159 patients diagnosed with liver hydatid cysts. Demographic, clinical, laboratory, and imaging data were collected. Cysts were classified according to the WHO Informal Working Group on Echinococcosis (WHO-IWGE) and Gharbi systems. Ultrasound findings were compared with computed tomography (CT), and their association with treatment decisions was assessed. Result: A total of 159 patients with liver hydatid cysts were included in the study. Among them, 91 (57.2%) were female, 80 (50.3%) were aged 20–39 years, and 128 (80.5%) resided in rural areas. Most patients presented with a single cyst (144/159, 90.6%), while multiple cysts were observed in 15 (9.4%). The majority of cysts measured 5–9.9 cm in diameter (43.4%), followed by 1–4.9 cm (42.1%) and ≥10 cm (14.5%). According to the WHO-IWGE classification, CE1 (25.8%) and CE4 (24.5%) were the most common stages, followed by CE2 (17.6%), CE3a (13.8%), CE3b (11.3%), and CE5 (7.0%). Common exposure-related factors included dog ownership, poor hygiene practices, and consumption of raw vegetables. Ultrasound accurately identified cyst stages and demonstrated a significant association between WHO-IWGE staging and treatment modality (χ2 = 63.56, p < 0.001). Almost perfect agreement was observed between ultrasound and CT for cyst classification (Cohen’s κ > 0.90), although CT provided additional anatomical information in selected complex cases. Conclusions: Ultrasound is an accessible, accurate, and reliable imaging modality for the diagnosis, staging, and management of liver hydatid cysts. In resource-limited settings, it serves as the primary imaging modality for guiding clinical decision-making, with CT reserved for complex or uncertain cases.
- Open Access
- 26 May 2026
- Published by MDPI AG in Preprints.org
Ultrasound-Based Staging and Its Impact on Clinical Management of Hepatic Hydatid Cysts in an Endemic Setting: A Cross-Sectional Study in Eastern Afghanistan
Background: Hydatid disease, caused by Echinococcus granulosus, remains a significant public health concern in endemic regions. This study aimed to evaluate the role of ultrasound in the diagnosis, staging, and clinical management of liver hydatid cysts in eastern city Jalalabad, Afghanistan. Method: A cross-sectional study was conducted between February and November 2024 among 159 patients diagnosed with liver hydatid cysts. Demographic, clinical, laboratory, and imaging data were collected. Cysts were classified according to the WHO Informal Working Group on Echinococcosis (WHO-IWGE) and Gharbi systems. Ultrasound findings were compared with computed tomography (CT), and their association with treatment decisions was assessed. Result: Most patients were female (57.2%), aged 20–39 years, and from rural areas (80.5%). Common exposure-related factors included poor hygiene, dog ownership, and consumption of raw vegetables. Ultrasound effectively identified cyst stages and guided management decisions, with a significant association between WHO staging and treatment modality (χ² = 63.56, p < 0.001). There was almost perfect agreement between ultrasound and CT in cyst classification (Cohen’s κ > 0.9), although CT provided additional anatomical details in selected cases. Conclusion: Ultrasound is an accessible, accurate, and reliable tool for the diagnosis, staging, and management of liver hydatid cysts. In resource-limited settings, it serves as the primary imaging modality for guiding clinical decision-making, with CT reserved for complex or uncertain cases.
- 26 May 2026
- Published by MDPI AG in Preprints.org
Open AccessUltrasound-Based Staging and Its Impact on Clinical Management of Hepatic Hydatid Cysts in an Endemic Setting: A Cross-Sectional Study in Eastern Afghanistan
Background: Hydatid disease, caused by Echinococcus granulosus, remains a significant public health concern in endemic regions. This study aimed to evaluate the role of ultrasound in the diagnosis, staging, and clinical management of liver hydatid cysts in eastern city Jalalabad, Afghanistan. Method: A cross-sectional study was conducted between February and November 2024 among 159 patients diagnosed with liver hydatid cysts. Demographic, clinical, laboratory, and imaging data were collected. Cysts were classified according to the WHO Informal Working Group on Echinococcosis (WHO-IWGE) and Gharbi systems. Ultrasound findings were compared with computed tomography (CT), and their association with treatment decisions was assessed. Result: Most patients were female (57.2%), aged 20–39 years, and from rural areas (80.5%). Common exposure-related factors included poor hygiene, dog ownership, and consumption of raw vegetables. Ultrasound effectively identified cyst stages and guided management decisions, with a significant association between WHO staging and treatment modality (χ² = 63.56, p < 0.001). There was almost perfect agreement between ultrasound and CT in cyst classification (Cohen’s κ > 0.9), although CT provided additional anatomical details in selected cases. Conclusion: Ultrasound is an accessible, accurate, and reliable tool for the diagnosis, staging, and management of liver hydatid cysts. In resource-limited settings, it serves as the primary imaging modality for guiding clinical decision-making, with CT reserved for complex or uncertain cases.
- Open Access
- 17 January 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Expression of sphingosine-1-phosphate receptor 1 in the brain of fatal cerebral malaria
The signaling pathway activated by sphingosine-1-phosphate (S1P) through S1P receptor 1 (S1PR1) plays specific roles in regulating vascular integrity and preventing vascular leakage during inflammatory response. Endothelial cell barrier dysfunction has been implicated in cerebral malaria (CM) pathology. To explore the S1P/S1PR1 signaling pathway in CM, the study investigated the expression of S1PR1 in the brain of fatal malaria and correlated with the level of S1P and malaria severity. Localisation of S1PR1 in brain tissues was evaluated using immunohistochemistry technique in archived brain tissues of fatal P. falciparum malaria. S1P level was determined using enzyme-linked immunosorbent assay (ELISA). S1PR1 expression was intense in cerebral blood vessels and neurons of fatal CM patients compared to brain tissues from control group and non-CM patients (all p < 0.001). S1P level in the blood decreased significantly in CM group and was negatively correlated with S1PR1 expression in blood vessels and neurons. The expression of S1PR1 in cerebral blood vessels and neurons indicates that S1P/S1PR1 signaling pathway is involved in malaria pathogenesis and represents potential targets for S1P/S1PR1 modulators to treat CM. The outcomes can serve as a basis to explore measures to block the expression of S1PR1 which could reduce sequestration.
- 17 January 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessExpression of sphingosine-1-phosphate receptor 1 in the brain of fatal cerebral malaria
The signaling pathway activated by sphingosine-1-phosphate (S1P) through S1P receptor 1 (S1PR1) plays specific roles in regulating vascular integrity and preventing vascular leakage during inflammatory response. Endothelial cell barrier dysfunction has been implicated in cerebral malaria (CM) pathology. To explore the S1P/S1PR1 signaling pathway in CM, the study investigated the expression of S1PR1 in the brain of fatal malaria and correlated with the level of S1P and malaria severity. Localisation of S1PR1 in brain tissues was evaluated using immunohistochemistry technique in archived brain tissues of fatal P. falciparum malaria. S1P level was determined using enzyme-linked immunosorbent assay (ELISA). S1PR1 expression was intense in cerebral blood vessels and neurons of fatal CM patients compared to brain tissues from control group and non-CM patients (all p < 0.001). S1P level in the blood decreased significantly in CM group and was negatively correlated with S1PR1 expression in blood vessels and neurons. The expression of S1PR1 in cerebral blood vessels and neurons indicates that S1P/S1PR1 signaling pathway is involved in malaria pathogenesis and represents potential targets for S1P/S1PR1 modulators to treat CM. The outcomes can serve as a basis to explore measures to block the expression of S1PR1 which could reduce sequestration.
- Open Access
- 1 January 2026
- Published by Wiley in Scientifica
- Vol. 2026 (1)
Antimalarial Activity and Safety Profile of Gaysorn‐Tang‐Ha (GSTH): A Thai Herbal Recipe Evaluated in an ICR Model
Natural compounds have gained considerable attention in the search for novel therapeutic agents, particularly for infectious diseases such as malaria. Traditional herbal medicines offer promising alternatives to address the growing challenge of drug‐resistant Plasmodium strains. This study evaluated the antimalarial activity and safety profile of a Thai herbal recipe, Gaysorn‐Tang‐Ha (GSTH), or five‐flower remedy, using in vivo mouse models, including 4‐day suppressive tests and acute toxicity assessments. Furthermore, gas chromatography–tandem mass spectrometry (GC–MS/MS) was employed to characterize the chemical constituents of the ethanolic extract. Chemical profiling revealed that the GSTH extract predominantly contained terpenoid compounds and fatty acid derivatives, with squalene identified as a major constituent. In antimalarial assays, GSTH extract exhibited dose‐dependent suppression of parasitemia, with suppression rates of 18.31%, 47.31%, and 61.49% at doses of 200, 400, and 600 mg/kg body weight, respectively. Parasitemia suppression in GSTH‐treated mice at all doses was significantly higher ( p < 0.05) than in the negative control. Acute toxicity testing revealed no observable physical or behavioral abnormalities in GSTH‐treated mice compared to the normal control group during 14 days. Additionally, there were no significant changes in body weight, liver, or kidney enzyme levels. Histopathological analysis of liver and kidney tissues showed no evidence of tissue damage, further supporting the safety of the extract. In conclusion, GSTH demonstrated significant dose‐dependent antimalarial activity, particularly at 600 mg/kg body weight, without observable signs of toxicity at doses up to 2 g/kg body weight. These findings indicate that the ethanolic GSTH extract exhibits moderate in vivo antimalarial activity with no evident acute toxicity under the conditions tested. The results provide preliminary evidence supporting further pharmacological and mechanistic investigations to better define its therapeutic potential.
- 1 January 2026
- Published by Wiley in Scientifica
- Vol. 2026 (1)
Open AccessAntimalarial Activity and Safety Profile of Gaysorn‐Tang‐Ha (GSTH): A Thai Herbal Recipe Evaluated in an ICR Model
Natural compounds have gained considerable attention in the search for novel therapeutic agents, particularly for infectious diseases such as malaria. Traditional herbal medicines offer promising alternatives to address the growing challenge of drug‐resistant Plasmodium strains. This study evaluated the antimalarial activity and safety profile of a Thai herbal recipe, Gaysorn‐Tang‐Ha (GSTH), or five‐flower remedy, using in vivo mouse models, including 4‐day suppressive tests and acute toxicity assessments. Furthermore, gas chromatography–tandem mass spectrometry (GC–MS/MS) was employed to characterize the chemical constituents of the ethanolic extract. Chemical profiling revealed that the GSTH extract predominantly contained terpenoid compounds and fatty acid derivatives, with squalene identified as a major constituent. In antimalarial assays, GSTH extract exhibited dose‐dependent suppression of parasitemia, with suppression rates of 18.31%, 47.31%, and 61.49% at doses of 200, 400, and 600 mg/kg body weight, respectively. Parasitemia suppression in GSTH‐treated mice at all doses was significantly higher ( p < 0.05) than in the negative control. Acute toxicity testing revealed no observable physical or behavioral abnormalities in GSTH‐treated mice compared to the normal control group during 14 days. Additionally, there were no significant changes in body weight, liver, or kidney enzyme levels. Histopathological analysis of liver and kidney tissues showed no evidence of tissue damage, further supporting the safety of the extract. In conclusion, GSTH demonstrated significant dose‐dependent antimalarial activity, particularly at 600 mg/kg body weight, without observable signs of toxicity at doses up to 2 g/kg body weight. These findings indicate that the ethanolic GSTH extract exhibits moderate in vivo antimalarial activity with no evident acute toxicity under the conditions tested. The results provide preliminary evidence supporting further pharmacological and mechanistic investigations to better define its therapeutic potential.
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Tropical Medicine
- Vol. 2026 (1)
Unveiling the Antimalarial Potential of Leaf Extracts of Mussaenda erythrophylla Schum. & Thonn. and Mussaenda philippica Dona Luz x M. flava in Mice
Malaria remains a major global public health concern, particularly in tropical regions. The increasing resistance to the current antimalarial drugs highlights the urgent need for new and effective therapies. Medicinal plants offer a promising source of novel and affordable antimalarial compounds for drug development. This study aimed to evaluate the antimalarial potential and acute oral toxicity of ethanolic leaf extract of Mussaenda erythrophylla Schum. & Thonn. ( M. erythrophylla or Dona Trining) and Mussaenda philippica Dona Luz x M. flava ( M. philippica or Dona Marmalade). Male Institute of Cancer Research (ICR) mice were treated with crude extracts at doses of 200, 400, and 600 mg/kg body weight, and the antimalarial activity was assessed using a 4‐day suppressive test against Plasmodium berghei ANKA strain. The ethanolic leaf extract of M. erythrophylla exhibited a parasite suppression of 12.31%, 39.59%, and 59.76% at 200, 400, and 600 mg/kg, respectively. Similarly, M. philippica leaf extract suppressed parasitemia by 36.18%, 36.40%, and 71.02% at the corresponding doses. All extract concentrations, except for the 200 mg/kg dose of M. erythrophylla , exhibited higher effects compared to the negative controls ( p < 0.05). At a dose of 2000 mg/kg, acute oral toxicity testing revealed no changes in ALT, ALP, BUN, or creatinine levels compared to controls, although AST levels were elevated. This increase was considered a possible mild adaptive response rather than a sign of overt toxicity. No alterations were observed in the physical activity or behavior of the mice, including piloerection, lacrimation, feeding activity, abnormal secretions, sleep patterns, or unusual excitement. Additionally, neither crude extract induced histological alterations in liver or kidney tissues. In conclusion, ethanolic leaf extracts of M. erythrophylla and M. philippica demonstrated promising antimalarial activity and were deemed safe at the tested doses, demonstrating safety up to 2000 mg/kg with only mild AST elevation and no observable histopathological damage. Extending the previous in vitro results of potent antimalarial activity and low cytotoxicity, our in vivo findings strongly support the efficacy and safety of these extracts. Further research is recommended to isolate and identify the active compounds responsible for the observed effects.
- 1 January 2026
- Published by Wiley in Journal of Tropical Medicine
- Vol. 2026 (1)
Open AccessUnveiling the Antimalarial Potential of Leaf Extracts of Mussaenda erythrophylla Schum. & Thonn. and Mussaenda philippica Dona Luz x M. flava in Mice
Malaria remains a major global public health concern, particularly in tropical regions. The increasing resistance to the current antimalarial drugs highlights the urgent need for new and effective therapies. Medicinal plants offer a promising source of novel and affordable antimalarial compounds for drug development. This study aimed to evaluate the antimalarial potential and acute oral toxicity of ethanolic leaf extract of Mussaenda erythrophylla Schum. & Thonn. ( M. erythrophylla or Dona Trining) and Mussaenda philippica Dona Luz x M. flava ( M. philippica or Dona Marmalade). Male Institute of Cancer Research (ICR) mice were treated with crude extracts at doses of 200, 400, and 600 mg/kg body weight, and the antimalarial activity was assessed using a 4‐day suppressive test against Plasmodium berghei ANKA strain. The ethanolic leaf extract of M. erythrophylla exhibited a parasite suppression of 12.31%, 39.59%, and 59.76% at 200, 400, and 600 mg/kg, respectively. Similarly, M. philippica leaf extract suppressed parasitemia by 36.18%, 36.40%, and 71.02% at the corresponding doses. All extract concentrations, except for the 200 mg/kg dose of M. erythrophylla , exhibited higher effects compared to the negative controls ( p < 0.05). At a dose of 2000 mg/kg, acute oral toxicity testing revealed no changes in ALT, ALP, BUN, or creatinine levels compared to controls, although AST levels were elevated. This increase was considered a possible mild adaptive response rather than a sign of overt toxicity. No alterations were observed in the physical activity or behavior of the mice, including piloerection, lacrimation, feeding activity, abnormal secretions, sleep patterns, or unusual excitement. Additionally, neither crude extract induced histological alterations in liver or kidney tissues. In conclusion, ethanolic leaf extracts of M. erythrophylla and M. philippica demonstrated promising antimalarial activity and were deemed safe at the tested doses, demonstrating safety up to 2000 mg/kg with only mild AST elevation and no observable histopathological damage. Extending the previous in vitro results of potent antimalarial activity and low cytotoxicity, our in vivo findings strongly support the efficacy and safety of these extracts. Further research is recommended to isolate and identify the active compounds responsible for the observed effects.
- Open Access
- 1 December 2025
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 10 (12) , 340
An Unusual Presentation of Human Parotid Filariasis
Human filariasis caused by Wuchereria bancrofti and Brugia malayi continues to circulate within Northern and Central Thailand and Southern Thailand, respectively. Major clinical presentations comprise lymphedema of extremities, hydrocele, funiculitis, orchitis, and tropical pulmonary eosinophilia. Microfilaria in other organs is rare. We report an unusual case of a 48-year-old woman from Southern Thailand with parotid filariasis presenting with chronic parotid gland enlargement. Wuchereria bancrofti microfilaria was observed within cytologic smear samples from the swollen left parotid gland and subsequently confirmed via a positive filaria immunoblot. The patient’s condition was successfully resolved through administration of a triple regimen consisting of three antiparasitic medications.
- 1 December 2025
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 10 (12) , 340
Open AccessAn Unusual Presentation of Human Parotid Filariasis
Human filariasis caused by Wuchereria bancrofti and Brugia malayi continues to circulate within Northern and Central Thailand and Southern Thailand, respectively. Major clinical presentations comprise lymphedema of extremities, hydrocele, funiculitis, orchitis, and tropical pulmonary eosinophilia. Microfilaria in other organs is rare. We report an unusual case of a 48-year-old woman from Southern Thailand with parotid filariasis presenting with chronic parotid gland enlargement. Wuchereria bancrofti microfilaria was observed within cytologic smear samples from the swollen left parotid gland and subsequently confirmed via a positive filaria immunoblot. The patient’s condition was successfully resolved through administration of a triple regimen consisting of three antiparasitic medications.
- Open Access
- 5 January 2024
- Published by Springer Nature in Malaria Journal
- Vol. 23 (1) , 1-14
Immunofluorescence study of cytoskeleton in endothelial cells induced with malaria sera
Background: Endothelial cells (ECs) play a major role in malaria pathogenesis, as a point of direct contact of parasitized red blood cells to the blood vessel wall. The study of cytoskeleton structures of ECs, whose main functions are to maintain shape and provide strength to the EC membrane is important in determining the severe sequelae of Plasmodium falciparum malaria. The work investigated the cytoskeletal changes (microfilaments-actin, microtubules-tubulin and intermediate filaments-vimentin) in ECs induced by malaria sera (Plasmodium vivax, uncomplicated P. falciparum and complicated P. falciparum), in relation to the levels of pro-inflammatory cytokines. Methods: Morphology and fluorescence intensity of EC cytoskeleton stimulated with malaria sera were evaluated using immunofluorescence technique. Levels of tumour necrosis factor (TNF) and interferon (IFN)-gamma (γ) were determined using enzyme-linked immunosorbent assay (ELISA). Control experimental groups included ECs incubated with media alone and non-malaria patient sera. Experimental groups consisted of ECs incubated with malaria sera from P. vivax, uncomplicated P. falciparum and complicated P. falciparum. Morphological scores of cytoskeletal alterations and fluorescence intensity were compared across each experiment group, and correlated with TNF and IFN-γ. Results: The four morphological changes of cytoskeleton included (1) shrinkage of cytoskeleton and ECs with cortical condensation, (2) appearance of eccentric nuclei, (3) presence of “spiking pattern” of cytoskeleton and EC membrane, and (4) fragmentation and discontinuity of cytoskeleton and ECs. Significant damages were noted in actin filaments compared to tubulin and vimentin filaments in ECs stimulated with sera from complicated P. falciparum malaria. Morphological damages to cytoskeleton was positively correlated with fluorescence intensity and the levels of TNF and IFN-γ. Conclusions: ECs stimulated with sera from complicated P. falciparum malaria showed cytoskeletal alterations and increased in fluorescence intensity, which was associated with high levels of TNF and IFN-γ. Cytoskeletal changes of ECs incubated with complicated P. falciparum malaria sera can lead to EC junctional alteration and permeability changes, which is mediated through apoptotic pathway. The findings can serve as a basis to explore measures to strengthen EC cytoskeleton and alleviate severe malaria complications such as pulmonary oedema and cerebral malaria. In addition, immunofluorescence intensity of cytoskeleton could be investigated as potential prognostic indicator for malaria severity.
- 5 January 2024
- Published by Springer Nature in Malaria Journal
- Vol. 23 (1) , 1-14
Open AccessImmunofluorescence study of cytoskeleton in endothelial cells induced with malaria sera
Background: Endothelial cells (ECs) play a major role in malaria pathogenesis, as a point of direct contact of parasitized red blood cells to the blood vessel wall. The study of cytoskeleton structures of ECs, whose main functions are to maintain shape and provide strength to the EC membrane is important in determining the severe sequelae of Plasmodium falciparum malaria. The work investigated the cytoskeletal changes (microfilaments-actin, microtubules-tubulin and intermediate filaments-vimentin) in ECs induced by malaria sera (Plasmodium vivax, uncomplicated P. falciparum and complicated P. falciparum), in relation to the levels of pro-inflammatory cytokines. Methods: Morphology and fluorescence intensity of EC cytoskeleton stimulated with malaria sera were evaluated using immunofluorescence technique. Levels of tumour necrosis factor (TNF) and interferon (IFN)-gamma (γ) were determined using enzyme-linked immunosorbent assay (ELISA). Control experimental groups included ECs incubated with media alone and non-malaria patient sera. Experimental groups consisted of ECs incubated with malaria sera from P. vivax, uncomplicated P. falciparum and complicated P. falciparum. Morphological scores of cytoskeletal alterations and fluorescence intensity were compared across each experiment group, and correlated with TNF and IFN-γ. Results: The four morphological changes of cytoskeleton included (1) shrinkage of cytoskeleton and ECs with cortical condensation, (2) appearance of eccentric nuclei, (3) presence of “spiking pattern” of cytoskeleton and EC membrane, and (4) fragmentation and discontinuity of cytoskeleton and ECs. Significant damages were noted in actin filaments compared to tubulin and vimentin filaments in ECs stimulated with sera from complicated P. falciparum malaria. Morphological damages to cytoskeleton was positively correlated with fluorescence intensity and the levels of TNF and IFN-γ. Conclusions: ECs stimulated with sera from complicated P. falciparum malaria showed cytoskeletal alterations and increased in fluorescence intensity, which was associated with high levels of TNF and IFN-γ. Cytoskeletal changes of ECs incubated with complicated P. falciparum malaria sera can lead to EC junctional alteration and permeability changes, which is mediated through apoptotic pathway. The findings can serve as a basis to explore measures to strengthen EC cytoskeleton and alleviate severe malaria complications such as pulmonary oedema and cerebral malaria. In addition, immunofluorescence intensity of cytoskeleton could be investigated as potential prognostic indicator for malaria severity.
- Open Access
- 20 September 2023
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 23 (1) , 1-20
Efficacy of artesunate combined with Atractylodes lancea or Prabchompoothaweep remedy extracts as adjunctive therapy for the treatment of cerebral malaria
Background: Cerebral malaria is one of the most serious complications of Plasmodium infection and causes behavioral changes. However, current antimalarial drugs have shown poor outcomes. Therefore, new antimalarials with neuroprotective effects are urgently needed. This study aimed to evaluate the effects of selected extracts as monotherapy or adjunctive therapy with artesunate on antimalarial, anti-inflammatory, antioxidant, and neuroprotective properties in experimental cerebral malaria (ECM). Methods: ECM was induced in male C57BL/6 mice by infection with Plasmodium berghei ANKA (PbA). Ethanolic extracts of Atractylodes lancea (a dose of 400 mg/kg) and Prabchompoothaweep remedy (a dose of 600 mg/kg) were evaluated as monotherapy and adjunctive therapy combined with artesunate at the onset of signs of cerebral malaria and continued for 7 consecutive days. Parasitemia, clinical scores, and body weight were recorded throughout the study. At day 13 post-infection, mouse brains were dissected and processed for the study of the inflammatory response, oxidative stress, blood–brain barrier (BBB) integrity, histopathological changes, and neurocognitive impairments. Results: Ethanolic extracts of A. lancea and Prabchompoothaweep remedy alone improved cerebral malaria outcome in ECM, whereas artesunate combined with extracts of A. lancea or Prabchompoothaweep remedy significantly improved the outcome of artesunate and crude extracts alone. Using real-time PCR, PbA-infected mice that had received the combination treatment showed significantly reduced gene expression of inflammatory cytokines (TNF-α, IL-1β, IL-6, and IL-10), chemokines (CXCL4 and CXCL10), and adhesion molecules (ICAM-1, VCAM1, and CD36). The PbA-infected mice that received the combination treatment showed a significantly decreased malondialdehyde level compared to the untreated group. Similarly, the Evans blue dye assay revealed significantly less dye extravasation in the brains of infected mice administered the combination treatment, indicating improved BBB integrity. Combination treatment improved survival and reduced pathology in the PbA-infected group. Additionally, combination treatment resulted in a significantly reduced level of cognitive impairment, which was analyzed using a novel object recognition test. Conclusions: This study demonstrated that artesunate combined with A. lancea or Prabchompoothaweep remedy extracts as adjunctive therapy reduced mortality, neuroinflammation, oxidative stress, BBB integrity protection, and neurocognitive impairment in the ECM.
- 20 September 2023
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 23 (1) , 1-20
Open AccessEfficacy of artesunate combined with Atractylodes lancea or Prabchompoothaweep remedy extracts as adjunctive therapy for the treatment of cerebral malaria
Background: Cerebral malaria is one of the most serious complications of Plasmodium infection and causes behavioral changes. However, current antimalarial drugs have shown poor outcomes. Therefore, new antimalarials with neuroprotective effects are urgently needed. This study aimed to evaluate the effects of selected extracts as monotherapy or adjunctive therapy with artesunate on antimalarial, anti-inflammatory, antioxidant, and neuroprotective properties in experimental cerebral malaria (ECM). Methods: ECM was induced in male C57BL/6 mice by infection with Plasmodium berghei ANKA (PbA). Ethanolic extracts of Atractylodes lancea (a dose of 400 mg/kg) and Prabchompoothaweep remedy (a dose of 600 mg/kg) were evaluated as monotherapy and adjunctive therapy combined with artesunate at the onset of signs of cerebral malaria and continued for 7 consecutive days. Parasitemia, clinical scores, and body weight were recorded throughout the study. At day 13 post-infection, mouse brains were dissected and processed for the study of the inflammatory response, oxidative stress, blood–brain barrier (BBB) integrity, histopathological changes, and neurocognitive impairments. Results: Ethanolic extracts of A. lancea and Prabchompoothaweep remedy alone improved cerebral malaria outcome in ECM, whereas artesunate combined with extracts of A. lancea or Prabchompoothaweep remedy significantly improved the outcome of artesunate and crude extracts alone. Using real-time PCR, PbA-infected mice that had received the combination treatment showed significantly reduced gene expression of inflammatory cytokines (TNF-α, IL-1β, IL-6, and IL-10), chemokines (CXCL4 and CXCL10), and adhesion molecules (ICAM-1, VCAM1, and CD36). The PbA-infected mice that received the combination treatment showed a significantly decreased malondialdehyde level compared to the untreated group. Similarly, the Evans blue dye assay revealed significantly less dye extravasation in the brains of infected mice administered the combination treatment, indicating improved BBB integrity. Combination treatment improved survival and reduced pathology in the PbA-infected group. Additionally, combination treatment resulted in a significantly reduced level of cognitive impairment, which was analyzed using a novel object recognition test. Conclusions: This study demonstrated that artesunate combined with A. lancea or Prabchompoothaweep remedy extracts as adjunctive therapy reduced mortality, neuroinflammation, oxidative stress, BBB integrity protection, and neurocognitive impairment in the ECM.
- Open Access
- 14 July 2023
- Published by Springer Nature in Research Square
Immunofluorescence study of cytoskeleton in endothelial cells induced with malaria sera
Background Endothelial cells (ECs) play a major role in malaria pathogenesis, as a point of direct contact of parasitized red blood cells to the blood vessel wall. The study of cytoskeleton structures of ECs, whose main functions are to maintain shape and provide strength to the EC membrane is important in determining the severe sequelae of Plasmodium falciparum malaria. The work investigated the cytoskeletal changes (microfilaments- actin, microtubules- tubulin and intermediate filaments- vimentin) in ECs induced by malaria sera (P. vivax, uncomplicated P. falciparum and complicated P. falciparum).Methods Morphology and fluorescence intensity of EC cytoskeleton stimulated with malaria sera were evaluated using immunofluorescence technique. Control experimental groups included ECs incubated with media alone and with normal sera. Experimental groups consisted of ECs incubated with malaria sera from P. vivax, uncomplicated P. falciparum and complicated P. falciparum. Morphological scores of cytoskeletal alterations and fluorescence intensity were compared across each experiment groupResults The four morphological changes of cytoskeleton included (1) shrinkage of cytoskeleton and ECs with cortical condensation, (2) appearance of eccentric nuclei, (3) presence of “spiking pattern” of cytoskeleton and EC membrane, and (4) fragmentation and discontinuity of cytoskeleton and ECs. Significant damages were noted in actin filaments compared to tubulin and vimentin filaments in ECs stimulated with sera from complicated P. falciparum malaria. Fluorescence intensity of EC cytoskeleton was also highest in ECs stimulated with sera from complicated P. falciparum malaria and was correlated with morphological damages to cytoskeleton.Conclusions ECs stimulated with sera from complicated P. falciparum malaria showed cytoskeletal alterations and increased in fluorescence intensity. Cytoskeletal changes of ECs incubated with complicated P. falciparum malaria sera can lead to EC junctional alteration and permeability changes, which is mediated through apoptotic pathway. The findings can serve as a basis to explore measures to strengthen EC cytoskeleton and alleviate severe malaria complications such as pulmonary oedema and cerebral malaria. In addition, immunofluorescence intensity of cytoskeleton could be investigated as potential prognostic indicator for malaria severity.
- 14 July 2023
- Published by Springer Nature in Research Square
Open AccessImmunofluorescence study of cytoskeleton in endothelial cells induced with malaria sera
Background Endothelial cells (ECs) play a major role in malaria pathogenesis, as a point of direct contact of parasitized red blood cells to the blood vessel wall. The study of cytoskeleton structures of ECs, whose main functions are to maintain shape and provide strength to the EC membrane is important in determining the severe sequelae of Plasmodium falciparum malaria. The work investigated the cytoskeletal changes (microfilaments- actin, microtubules- tubulin and intermediate filaments- vimentin) in ECs induced by malaria sera (P. vivax, uncomplicated P. falciparum and complicated P. falciparum).Methods Morphology and fluorescence intensity of EC cytoskeleton stimulated with malaria sera were evaluated using immunofluorescence technique. Control experimental groups included ECs incubated with media alone and with normal sera. Experimental groups consisted of ECs incubated with malaria sera from P. vivax, uncomplicated P. falciparum and complicated P. falciparum. Morphological scores of cytoskeletal alterations and fluorescence intensity were compared across each experiment groupResults The four morphological changes of cytoskeleton included (1) shrinkage of cytoskeleton and ECs with cortical condensation, (2) appearance of eccentric nuclei, (3) presence of “spiking pattern” of cytoskeleton and EC membrane, and (4) fragmentation and discontinuity of cytoskeleton and ECs. Significant damages were noted in actin filaments compared to tubulin and vimentin filaments in ECs stimulated with sera from complicated P. falciparum malaria. Fluorescence intensity of EC cytoskeleton was also highest in ECs stimulated with sera from complicated P. falciparum malaria and was correlated with morphological damages to cytoskeleton.Conclusions ECs stimulated with sera from complicated P. falciparum malaria showed cytoskeletal alterations and increased in fluorescence intensity. Cytoskeletal changes of ECs incubated with complicated P. falciparum malaria sera can lead to EC junctional alteration and permeability changes, which is mediated through apoptotic pathway. The findings can serve as a basis to explore measures to strengthen EC cytoskeleton and alleviate severe malaria complications such as pulmonary oedema and cerebral malaria. In addition, immunofluorescence intensity of cytoskeleton could be investigated as potential prognostic indicator for malaria severity.
- Open Access
- 4 May 2023
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 23 (1) , 1-13
Preclinical evaluation of antimalarial activity of CPF-1 formulation as an alternative choice for the treatment of malaria
Background: Kheaw Hom remedy is a traditional Thai medicine used to treat fever. Some plants used in the Kheaw Hom remedy show promising in vitro antimalarial activity. This study prepared novel formulations of plants from the Kheaw Hom remedy and evaluated their antimalarial and toxicological activities.Methods: Seven new formulations were prepared by combining at least three herbs of six selected plants from the Kheaw Hom remedy, namelyMammea siamensisKosterm.,Mesua ferreaL.,Dracaena loureiroiGagnep.,Pogostemon cablin(Blanco) Benth.,Kaempferia galangaL, andEupatorium stoechadosmumHance. In vitro antimalarial activities of each formulation’s aqueous and ethanolic extracts were evaluated using the parasite lactate dehydrogenase (pLDH) assay. Cytotoxicity in Vero and HepG2 cells was assessed using the MTT assay. An extract with good antimalarial potency and selectivity index (SI) was selected for in vivo antimalarial activity using Peter’s 4-day suppressive test and acute oral toxicity test in mice. In addition, bioactive compounds were identified using Gas chromatography-mass spectrometry (GC-MS) analysis.Results: Among the seven new formulations, ethanolic extracts of CPF-1 (Formulation 1) showed the highest activity with an IC50value of 1.32 ± 0.66 µg/ml, followed by ethanolic extracts of Formulation 4 and Formulation 6 with an IC50value of 1.52 ± 0.28 µg/ml and 2.48 ± 0.34 µg/ml, respectively. The highest SI values were obtained for the ethanolic extract of CPF-1 that was selected to confirm its in vivo antimalarial activity and toxicity. The results demonstrated a significant dose-dependent reduction in parasitemia. Maximum suppressive effect of the extract (72.01%) was observed at the highest dose administered (600 mg/kg). No significant toxicity was observed after the administration of 2000 mg/kg. Using GC-MS analysis, the most abundant compound in the ethanolic extract of CPF-1 was ethylp-methoxycinnamate (14.32%), followed by 2-propenoic acid, 3-phenyl-, ethyl ester, (E)- (2.50%), and pentadecane (1.85%).Conclusion: The ethanolic extract of CPF-1 showed promising in vitro and in vivo antimalarial efficacy, with no toxic effects at a dose of 2000 mg/kg, suggesting that the ethanolic extract of CPF-1 may serves as a new herbal formulation for the treatment of malaria. Additional research is required for safety and clinical pharmacology studies.
- 4 May 2023
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 23 (1) , 1-13
Open AccessPreclinical evaluation of antimalarial activity of CPF-1 formulation as an alternative choice for the treatment of malaria
Background: Kheaw Hom remedy is a traditional Thai medicine used to treat fever. Some plants used in the Kheaw Hom remedy show promising in vitro antimalarial activity. This study prepared novel formulations of plants from the Kheaw Hom remedy and evaluated their antimalarial and toxicological activities.Methods: Seven new formulations were prepared by combining at least three herbs of six selected plants from the Kheaw Hom remedy, namelyMammea siamensisKosterm.,Mesua ferreaL.,Dracaena loureiroiGagnep.,Pogostemon cablin(Blanco) Benth.,Kaempferia galangaL, andEupatorium stoechadosmumHance. In vitro antimalarial activities of each formulation’s aqueous and ethanolic extracts were evaluated using the parasite lactate dehydrogenase (pLDH) assay. Cytotoxicity in Vero and HepG2 cells was assessed using the MTT assay. An extract with good antimalarial potency and selectivity index (SI) was selected for in vivo antimalarial activity using Peter’s 4-day suppressive test and acute oral toxicity test in mice. In addition, bioactive compounds were identified using Gas chromatography-mass spectrometry (GC-MS) analysis.Results: Among the seven new formulations, ethanolic extracts of CPF-1 (Formulation 1) showed the highest activity with an IC50value of 1.32 ± 0.66 µg/ml, followed by ethanolic extracts of Formulation 4 and Formulation 6 with an IC50value of 1.52 ± 0.28 µg/ml and 2.48 ± 0.34 µg/ml, respectively. The highest SI values were obtained for the ethanolic extract of CPF-1 that was selected to confirm its in vivo antimalarial activity and toxicity. The results demonstrated a significant dose-dependent reduction in parasitemia. Maximum suppressive effect of the extract (72.01%) was observed at the highest dose administered (600 mg/kg). No significant toxicity was observed after the administration of 2000 mg/kg. Using GC-MS analysis, the most abundant compound in the ethanolic extract of CPF-1 was ethylp-methoxycinnamate (14.32%), followed by 2-propenoic acid, 3-phenyl-, ethyl ester, (E)- (2.50%), and pentadecane (1.85%).Conclusion: The ethanolic extract of CPF-1 showed promising in vitro and in vivo antimalarial efficacy, with no toxic effects at a dose of 2000 mg/kg, suggesting that the ethanolic extract of CPF-1 may serves as a new herbal formulation for the treatment of malaria. Additional research is required for safety and clinical pharmacology studies.